Keto vs Low Carb for Diabetics

Blood Glucose and HbA1c Improvements

Both ketogenic and low carb diets produce dramatic improvements in blood glucose markers for people with type 2 diabetes. A landmark 2018 randomized controlled trial by Hallberg et al. (the Virta Health study) found that a 46% of participants with type 2 diabetes achieved remission (HbA1c below 6.0% without glucose-lowering medication) after 2 years on a very low carb ketogenic diet. Average HbA1c dropped from 7.6% to 6.3% — a 1.3% reduction — compared to only a 0.3% reduction in the standard diabetes education group. A separate meta-analysis by Wang et al. (2019) pooling 13 RCTs found that low carb diets (including both keto and moderate low carb) reduced HbA1c by an average of 1.1-1.7% over 6-12 months, compared to 0.4-0.6% for conventional low-fat diabetes diets. Even moderate low carb diets of 80-120 g/day produce clinically meaningful HbA1c reductions of 0.8-1.2%, making them an effective and sustainable option.

Insulin Sensitivity and Medication Reduction

Carbohydrate restriction reduces postprandial blood glucose spikes directly, since glucose is the only macronutrient that requires insulin for cellular uptake. By drastically reducing the glucose load, the body\'s insulin demand falls proportionally, and insulin sensitivity improves as chronic hyperinsulinemia resolves. In the Virta Health cohort, 92.6% of participants reduced or eliminated their diabetes medications within 2 years, and the average daily insulin dose dropped by 97% in those who were on insulin at baseline. Metformin doses were reduced by an average of 50-70% within 3-6 months. These medication changes must be done under physician supervision, since reducing insulin or sulfonylureas too quickly while carb intake drops can cause dangerous hypoglycemia. Both keto and low carb diets produce these effects, though keto tends to produce faster and larger improvements due to the deeper carbohydrate restriction.

Medication Warnings: Critical Safety Information

Anyone with diabetes who starts a ketogenic or low carb diet must work closely with their physician to adjust medications. The three highest-risk medication classes are: insulin (rapid reduction in carb intake can cause severe hypoglycemia within 24-48 hours if insulin doses are not reduced proportionally), sulfonylureas like glipizide and glyburide (these stimulate insulin secretion regardless of blood glucose level and carry significant hypoglycemia risk on very low carb diets), and SGLT2 inhibitors like empagliflozin and dapagliflozin (these increase the risk of euglycemic diabetic ketoacidosis when combined with very low carb or ketogenic diets). SGLT2 inhibitors should be paused or discontinued before starting a ketogenic diet, as the combination can produce dangerous ketone elevation even with normal blood glucose levels — a condition called euglycemic DKA that is particularly dangerous because it lacks the classic warning sign of high blood sugar.

DKA Risk: Understanding the Distinction

Diabetic ketoacidosis (DKA) is a life-threatening complication where blood ketone levels exceed 3.0-5.0 mmol/L and blood pH drops below 7.3, causing metabolic acidosis. Nutritional ketosis on a ketogenic diet produces blood ketone levels of 0.5-3.0 mmol/L with normal blood pH — a fundamentally different and safe metabolic state. However, the risk is real for two populations. Type 1 diabetics who attempt keto without medical supervision risk DKA because they lack endogenous insulin to regulate ketone production. Type 2 diabetics on SGLT2 inhibitors who reduce carbs dramatically can develop euglycemic DKA — ketone levels exceeding 3.0 mmol/L with blood glucose below 250 mg/dL — which bypasses the typical high-blood-sugar warning sign. Blood ketone monitoring with a finger-stick meter (measuring beta-hydroxybutyrate, not urine acetoacetate) is essential for anyone with diabetes on a very low carb diet. If ketones exceed 3.0 mmol/L or you experience nausea, vomiting, or confusion, seek medical attention immediately.

Which Approach for Which Type of Diabetes?

For type 2 diabetes, both keto and moderate low carb diets are effective, with keto producing faster and larger improvements in the first 6 months and low carb (80-120 g/day) offering better long-term sustainability. Many endocrinologists now recommend starting with a moderate low carb approach (80-100 g/day) for 4-6 weeks to establish habits and monitor medication adjustments, then optionally reducing further to keto if additional improvement is desired and tolerated. For type 1 diabetes, carbohydrate restriction requires extreme caution and should only be attempted under close endocrinologist supervision with continuous glucose monitoring and frequent ketone checking. The International Society for Pediatric and Adolescent Diabetes (ISPAD) and the American Diabetes Association (ADA) both acknowledge low carb diets as an option for T1D management but caution that they do not eliminate DKA risk and require intensive glucose monitoring. For gestational diabetes, low carb diets (120-150 g/day) are increasingly used under obstetric supervision to manage blood glucose without medications.